Physician
Inman Medical Associates,llc
Inman Medical Associates,llc was paid $2.59M by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.
33Billing provider infoINMAN MEDICAL ASSOCIATES,LLC
COLONIA, NJ 07067
COLONIA, NJ 07067
33aNPI1073702205assigned 10/24/2007
33bProvider typeInternal Medicine Physician
28Total paid$2.59M
24GClaims126,579
24DCodes billed59
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in New Jersey
Rank by total paid#29 of 1,027
Median peer was paid$30K
This provider vs. median87×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,084 | $381K | |
| 2019 | 10,926 | $295K | |
| 2020 | 12,172 | $304K | |
| 2021 | 16,085 | $358K | |
| 2022 | 22,180 | $461K | |
| 2023 | 30,212 | $475K | |
| 2024incomplete | 21,920 | $321K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56% | 39,104 | 33,880 | $1.45M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 8.3% | 3,503 | 3,445 | $216K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 6.5% | 2,704 | 2,672 | $170K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.4% | 3,765 | 3,535 | $166K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.3% | 1,615 | 1,604 | $111K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 3.6% | 2,457 | 2,307 | $94K |
| 93000 | 2.1% | 5,137 | 5,007 | $56K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 7,970 | 7,132 | $52K |
| 90674 | 2.0% | 2,413 | 2,391 | $51K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.8% | 1,447 | 1,331 | $47K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.4% | 1,610 | 1,464 | $35K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 2,623 | 2,601 | $33K |
47 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 16,366 | $24K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,217 | $19K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 177 | $15K |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 1,639 | $10K |
| 93922 | <1% | 557 | $8K | |
| 99349 | <1% | 148 | $6K | |
| 90688 | <1% | 374 | $6K | |
| 99397 | <1% | 203 | $4K | |
| 96127 | <1% | 1,853 | $4K | |
| 90661 | <1% | 208 | $4K | |
| 99490 | Ccm add 20min | <1% | 2,871 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 414 | $2K |
| 81002 | <1% | 2,337 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,165 | $1K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 417 | $1K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 106 | $792.67 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 309 | $792.44 |
| 99343 | <1% | 20 | $564.33 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 13 | $537.94 |
| 90694 | <1% | 89 | $340.69 | |
| 99457 | <1% | 442 | $270.31 | |
| G0008 | Administration of influenza virus vaccine | <1% | 575 | $252.63 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 17 | $227.03 |
| 99497 | <1% | 69 | $220.75 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 177 | $211.99 |
| 99454 | <1% | 429 | $109.68 | |
| 81025 | <1% | 26 | $86.02 | |
| 88150 | <1% | 12 | $78.74 | |
| 3078F | <1% | 4,130 | $9.00 | |
| 99453 | <1% | 49 | $8.72 | |
| 3075F | <1% | 1,754 | $5.00 | |
| 3074F | <1% | 3,783 | $5.00 | |
| 3044F | <1% | 1,872 | $3.00 | |
| 3079F | <1% | 1,482 | $2.00 | |
| 1160F | 0% | 391 | $0.00 | |
| 3077F | 0% | 123 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 2,596 | $0.00 |
| 3288F | 0% | 452 | $0.00 | |
| 1159F | 0% | 392 | $0.00 | |
| 90653 | 0% | 30 | $0.00 | |
| 3046F | 0% | 52 | $0.00 | |
| 3051F | 0% | 64 | $0.00 | |
| 1126F | 0% | 506 | $0.00 | |
| 1123F | 0% | 523 | $0.00 | |
| 3017F | 0% | 345 | $0.00 | |
| 1170F | 0% | 442 | $0.00 | |
| Q2035 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJAIN, SAPNA (OFFICE MANAGER)